Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects:

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Subjects:

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for neutralizing monoclonal antibodies, among patients alive and with day 90 antibody and antigen measu... by Elizabeth S. Munroe (21568166)

Subjects:

Overview of the six original ACTIV-3/TICO trials. by Elizabeth S. Munroe (21568166)

Subjects:

Knockdown of p65 in A549 cells results in a decreased infection rate. by Janine J. Wilden (8849948)

Decreasing phagocytosis did not block NRF2 activation in <i>Lgy</i> infection. by Marta Reverte (10450927)

Decreased Tbx2 expression in the AV myocardium of <i>Ezh2</i> mutant mice. by Li Chen (5749)

Overexpression of GRK2 and β-arrestin-2 decreases cell surface GPR3 expression. by Katie M. Lowther (427408)

“…Densitometric values for surface GPR3 was divided by densitometric values for total GPR3 and normalized to GAPDH to compare the amount of GPR3 at the surface vs. total GPR3 expression. (*) indicates a significant decrease in surface/total GPR3 expression as a result of GRK2 and β-arrestin-2 overexpression. …”

a-c: Bone marrow (BM) EPO receptor (EPO-R) decreases in uremic anemia rats. by Daniel Landau (440830)

“…<p>BM EPO-R protein (depicted as percentage of actin-corrected concentration) is unchanged in 7 day-bled rats Vs controls (Fig. 4a). Contrary to that BM EPO-R protein decreases in uremic (4 weeks after 5/6 nephrectomy) rats (Fig. 4b). …”

Deletion of <i>ERG251-A</i> but not <i>ERG251-B</i> leads to decreased filamentation. by Xin Zhou (54275)

Subjects:

Decreased projections to LP in <i>Brn3b</i> mutants occur postnatally. by Hyoseo Lee (17419987)

“…(<b>H</b>) Quantification (1.00 ± 0.09 for control, 0.45 ± 0.03 for cKO); unpaired two-tailed Student’s <i>t</i> test (mean ± SEM; <i>p</i> < 0.0001 [****] at P4/P5; <i>p</i> = 0.0004 [***] at P8/P9; <i>p</i> = 0.0012 [**] at P12/P13). …”

Mucosal vaccination with M2e5x VLP decreases innate immune cell recruitments after influenza virus infection. by Young-Tae Lee (467116)

Cytochalasin D decreases pyroptosis in TLR ligand-activated Raw264.7 cells. by Peeraya Ekchariyawat (3911113)

DGAT-1 Inhibitor A922500 decreases the pro-inflammatory profile and cell death induced by SARS-CoV-2 infection and reduces the viral load in human monocyte. by Suelen Silva Gomes Dias (9928813)

Inhibition of NFAT activity with CsA and INCA-6 decreases CASQ2 mRNA synthesis in neonatal cardiomyocytes. by Rafael Estrada-Avilés (4424278)

CD5-2 decreases established CCM lesions in the hindbrain of <i>Ccm2</i>^<i>ECKO</i> mice and lesions in the retina of <i>Ccm2</i>^<i>ECKO</i> mice. by Jia Li (160557)

Decreased thrombin activity levels in PAR KO following 24 hours following ischemia. by Efrat Shavit-Stein (3186678)

“…<p>(A) Total thrombin activity is significantly decreased in PAR1 KO compared to WT mice (t-test). …”

Ly49C peptide dependent recognition of H-2K^b decreases with peptides bearing non-polar aliphatic auxiliary anchor residues. by Elsa A. Marquez (766160)

PPP2R5C HepKD in <i>db/db</i> mouse liver improves insulin sensitivity, decreases hyperglycemia, but worsens the dyslipidemia. by Yong-Sheng Cheng (803758)

“…<p><b>(A)</b> Hyperglycemia in <i>db/db</i> mice is decreased upon hypatocyte-specific PPP2R5C knockdown with adeno-associated virus. …”

AS021 activity and Satb2 expression decrease within deep layers at postnatal stages. by Kensuke Tashiro (193459)

“…(E–G″′) Immunostaining for Satb2 (red), Ctip2 (blue), and βgal (green) in coronal sections of P2 AS021-lacZ brains reveals a strong decrease of Satb2 staining specifically in deep layers. …”